Literature DB >> 18685776

Vanadium-vitamin B12 bioconjugates as potential therapeutics for treating diabetes.

Riya Mukherjee1, Edward G Donnay, Michal A Radomski, Catherine Miller, Duane A Redfern, Arne Gericke, Derek S Damron, Nicola E Brasch.   

Abstract

The synthesis and blood glucose lowering properties of the first vanadium-vitamin B(12) bioconjugates are reported.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18685776     DOI： 10.1039/b806598e

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN： 1359-7345            Impact factor:   6.222


  4 in total

1.  Oxidovanadium(IV) complexes with chrysin and silibinin: anticancer activity and mechanisms of action in a human colon adenocarcinoma model.

Authors:  I E León; J F Cadavid-Vargas; I Tiscornia; V Porro; S Castelli; P Katkar; A Desideri; M Bollati-Fogolin; S B Etcheverry
Journal:  J Biol Inorg Chem       Date:  2015-09-24       Impact factor: 3.358

2.  Ternary oxovanadium(IV) complexes of ONO-donor Schiff base and polypyridyl derivatives as protein tyrosine phosphatase inhibitors: synthesis, characterization, and biological activities.

Authors:  Caixia Yuan; Liping Lu; Xiaoli Gao; Yanbo Wu; Maolin Guo; Ying Li; Xueqi Fu; Miaoli Zhu
Journal:  J Biol Inorg Chem       Date:  2009-03-17       Impact factor: 3.358

3.  Chimeric design, synthesis, and biological assays of a new nonpeptide insulin-mimetic vanadium compound to inhibit protein tyrosine phosphatase 1B.

Authors:  Thomas Scior; José Antonio Guevara-García; F J Melendez; Hassan H Abdallah; Quoc-Tuan Do; Philippe Bernard
Journal:  Drug Des Devel Ther       Date:  2010-09-24       Impact factor: 4.162

Review 4.  Vanadium. Its role for humans.

Authors:  Dieter Rehder
Journal:  Met Ions Life Sci       Date:  2013
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.